Nifty
:
25722.10
Sensex
:
83938.71
-155.75 (-0.60%)
-465.75 (-0.55%)
Nifty
Sensex
:
:
25722.10
83938.71
-155.75 (-0.60%)
-465.75 (-0.55%)

Laurus Labs Ltd.

Pharmaceuticals & Drugs - API

Rating :
64/99

BSE: 540222 | NSE: LAURUSLABS

NSE BSE
953.65
31-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  970.9
  •  972.4
  •  950.2
  •  970.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1545420
  •  1483988457.95
  •  972.55
  •  474.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 51,526.29
  • 75.34
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 53,612.26
  • 0.13%
  • 10.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.59%
  • 8.39%
  • 23.34%
  • FII
  • DII
  • Others
  • 26.17%
  • 10.29%
  • 4.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.07
  • 2.90
  • -2.76

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.29
  • -7.41
  • -7.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.20
  • -18.47
  • -23.56

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.60
  • 36.06
  • 93.47

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.04
  • 7.62
  • 6.34

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.10
  • 24.03
  • 27.07

Earnings Forecasts:

(Updated: 01-11-2025)
Description
2024
2025
2026
2027
Adj EPS
6.65
12.19
16.63
21.54
P/E Ratio
143.41
78.23
57.35
44.27
Revenue
5507.86
6555.49
7584.58
8576.03
EBITDA
1055.28
1552.43
1930.92
2329.24
Net Income
358.32
657.86
896.83
1161.28
ROA
4.04
6
8
8
P/B Ratio
11.50
10.07
8.63
7.34
ROE
8.35
13.39
15.84
17.46
FCFF
-242.42
-23.67
87.61
512.11
FCFF Yield
-0.46
-0.04
0.17
0.97
Net Debt
2619.52
2699.5
2714.46
2701.7
BVPS
82.94
94.7
110.5
129.9

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Net Sales
1,653.47
1,223.70
35.12%
1,569.57
1,194.91
31.35%
1,720.30
1,439.67
19.49%
1,415.05
1,194.92
18.42%
Expenses
1,250.21
1,045.37
19.59%
1,187.44
1,023.71
15.99%
1,299.70
1,198.18
8.47%
1,129.90
1,013.50
11.48%
EBITDA
403.26
178.33
126.13%
382.13
171.20
123.21%
420.60
241.49
74.17%
285.15
181.42
57.18%
EBIDTM
24.39%
14.57%
24.35%
14.33%
24.45%
16.77%
20.15%
15.18%
Other Income
26.96
4.60
486.09%
10.43
2.51
315.54%
58.57
18.53
216.08%
9.42
2.43
287.65%
Interest
40.00
52.61
-23.97%
51.50
49.19
4.70%
56.40
50.50
11.68%
57.80
50.82
13.73%
Depreciation
120.49
107.51
12.07%
116.84
106.06
10.16%
110.43
102.25
8.00%
106.09
98.41
7.80%
PBT
269.73
22.81
1,082.51%
224.22
18.46
1,114.63%
312.34
107.27
191.17%
130.68
34.62
277.47%
Tax
75.98
5.09
1,392.73%
63.14
6.25
910.24%
78.47
31.95
145.60%
40.07
9.45
324.02%
PAT
193.75
17.72
993.40%
161.08
12.21
1,219.25%
233.87
75.32
210.50%
90.61
25.17
259.99%
PATM
11.72%
1.45%
10.26%
1.02%
13.59%
5.23%
6.40%
2.11%
EPS
3.61
0.37
875.68%
3.02
0.23
1,213.04%
4.33
1.40
209.29%
1.71
0.43
297.67%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
6,358.39
5,553.96
5,040.83
6,040.55
4,935.57
4,813.51
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
Net Sales Growth
25.83%
10.18%
-16.55%
22.39%
2.54%
69.99%
23.55%
11.47%
7.96%
7.15%
 
Cost Of Goods Sold
2,693.62
2,395.08
2,374.35
2,729.67
2,133.89
2,107.62
1,382.88
1,224.80
1,056.02
989.29
1,000.15
Gross Profit
3,664.77
3,158.88
2,666.48
3,310.88
2,801.68
2,705.89
1,448.84
1,067.12
1,000.15
915.36
777.43
GP Margin
57.64%
56.88%
52.90%
54.81%
56.77%
56.21%
51.16%
46.56%
48.64%
48.06%
43.74%
Total Expenditure
4,867.25
4,498.68
4,263.33
4,448.36
3,513.14
3,262.83
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
Power & Fuel Cost
-
323.40
338.15
324.10
204.47
157.75
136.77
109.37
94.21
66.27
57.95
% Of Sales
-
5.82%
6.71%
5.37%
4.14%
3.28%
4.83%
4.77%
4.58%
3.48%
3.26%
Employee Cost
-
676.44
614.85
557.43
469.55
397.04
320.77
276.33
238.14
204.73
175.46
% Of Sales
-
12.18%
12.20%
9.23%
9.51%
8.25%
11.33%
12.06%
11.58%
10.75%
9.87%
Manufacturing Exp.
-
648.97
611.80
522.90
441.18
364.78
239.50
178.96
150.78
139.47
106.97
% Of Sales
-
11.68%
12.14%
8.66%
8.94%
7.58%
8.46%
7.81%
7.33%
7.32%
6.02%
General & Admin Exp.
-
201.69
157.89
151.15
146.49
133.28
114.23
97.48
73.17
65.42
49.09
% Of Sales
-
3.63%
3.13%
2.50%
2.97%
2.77%
4.03%
4.25%
3.56%
3.43%
2.76%
Selling & Distn. Exp.
-
170.95
134.49
116.14
101.98
91.65
61.53
31.96
24.09
22.65
16.49
% Of Sales
-
3.08%
2.67%
1.92%
2.07%
1.90%
2.17%
1.39%
1.17%
1.19%
0.93%
Miscellaneous Exp.
-
82.15
31.80
46.97
15.58
10.71
11.49
17.03
6.44
9.18
16.49
% Of Sales
-
1.48%
0.63%
0.78%
0.32%
0.22%
0.41%
0.74%
0.31%
0.48%
0.52%
EBITDA
1,491.14
1,055.28
777.50
1,592.19
1,422.43
1,550.68
564.55
355.99
413.32
407.64
362.20
EBITDA Margin
23.45%
19.00%
15.42%
26.36%
28.82%
32.22%
19.94%
15.53%
20.10%
21.40%
20.38%
Other Income
105.38
75.10
26.34
6.00
15.30
23.66
5.92
16.15
29.19
33.44
4.36
Interest
205.70
216.00
182.90
165.17
102.39
68.16
89.59
88.19
79.64
99.90
111.11
Depreciation
453.85
430.09
384.58
324.08
251.49
205.07
187.27
164.19
125.45
105.98
86.41
PBT
936.97
484.29
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
Tax
257.66
129.88
68.15
312.30
251.42
317.29
38.34
25.99
69.81
43.86
34.90
Tax Rate
27.50%
26.82%
28.83%
28.16%
23.20%
24.39%
13.06%
21.70%
29.40%
18.65%
20.65%
PAT
679.31
354.39
166.49
793.37
827.72
983.58
255.27
93.76
167.61
191.33
134.14
PAT before Minority Interest
681.39
354.41
168.21
796.64
832.43
983.82
255.27
93.76
167.61
191.33
134.14
Minority Interest
2.08
-0.02
-1.72
-3.27
-4.71
-0.24
0.00
0.00
0.00
0.00
0.00
PAT Margin
10.68%
6.38%
3.30%
13.13%
16.77%
20.43%
9.01%
4.09%
8.15%
10.05%
7.55%
PAT Growth
420.86%
112.86%
-79.01%
-4.15%
-15.85%
285.31%
172.26%
-44.06%
-12.40%
42.63%
 
EPS
12.58
6.57
3.08
14.70
15.33
18.22
4.73
1.74
3.11
3.54
2.48

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
4,472.56
4,110.95
4,037.53
3,351.19
2,597.55
1,769.77
1,558.41
1,482.64
1,330.45
856.80
Share Capital
107.85
107.79
107.73
107.47
107.32
106.91
106.44
106.03
105.76
82.38
Total Reserves
4,338.66
3,981.69
3,917.72
3,234.55
2,485.31
1,658.23
1,446.60
1,370.75
1,218.84
771.47
Non-Current Liabilities
1,193.33
1,159.18
1,179.48
927.98
692.84
214.24
295.49
174.30
132.34
428.11
Secured Loans
645.58
798.23
761.42
596.34
429.16
165.02
258.71
141.66
124.56
353.61
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
106.13
Long Term Provisions
106.09
93.47
81.47
72.67
63.19
45.85
30.05
20.84
14.59
6.77
Current Liabilities
3,539.72
3,112.28
2,432.26
2,681.01
2,457.15
1,692.38
1,423.90
1,306.89
1,120.75
883.75
Trade Payables
958.49
1,051.24
710.65
876.37
1,178.69
615.63
488.31
312.33
263.10
247.61
Other Current Liabilities
779.69
610.73
640.75
839.73
367.25
261.47
244.50
231.26
199.11
141.05
Short Term Borrowings
1,715.00
1,389.29
995.77
910.72
886.12
790.51
684.21
758.52
644.17
481.42
Short Term Provisions
86.54
61.02
85.09
54.19
25.09
24.77
6.89
4.78
14.37
13.66
Total Liabilities
9,335.57
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
Net Block
4,123.22
3,890.01
3,408.62
2,652.47
2,170.62
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
Gross Block
6,284.33
5,652.20
4,794.82
3,750.20
3,027.97
2,387.71
2,105.42
1,793.75
1,418.58
1,106.33
Accumulated Depreciation
2,161.11
1,762.19
1,386.20
1,097.73
857.35
661.37
476.35
312.95
188.65
85.30
Non Current Assets
5,003.25
4,552.06
4,198.72
3,623.43
2,675.83
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
Capital Work in Progress
458.36
422.84
550.78
813.22
362.17
67.18
109.63
163.18
143.26
69.60
Non Current Investment
233.26
123.98
49.90
30.81
3.41
3.41
3.40
3.40
3.40
7.04
Long Term Loans & Adv.
163.40
83.50
160.58
84.11
108.52
40.80
25.58
29.36
25.95
29.22
Other Non Current Assets
25.01
31.73
28.84
42.82
31.11
26.60
47.16
39.50
41.17
39.03
Current Assets
4,332.32
3,834.97
3,461.68
3,344.61
3,074.86
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,936.54
1,845.41
1,684.81
1,760.30
1,575.45
905.22
681.94
584.78
509.05
487.09
Sundry Debtors
2,007.16
1,662.92
1,580.44
1,354.18
1,306.06
791.42
709.94
570.59
567.61
444.86
Cash & Bank
144.21
141.65
48.46
75.94
48.46
1.74
3.02
3.06
4.09
28.77
Other Current Assets
244.41
37.83
39.07
19.71
144.89
113.68
68.06
89.16
59.08
42.00
Short Term Loans & Adv.
207.06
147.16
108.90
134.48
88.39
61.91
35.22
58.63
25.01
23.86
Net Current Assets
792.60
722.69
1,029.42
663.60
617.71
119.68
39.05
-59.30
19.07
118.98
Total Assets
9,335.57
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
601.65
665.69
993.90
911.10
733.00
347.42
297.66
342.49
331.99
181.97
PBT
484.29
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
Adjustment
629.50
562.92
485.71
351.13
254.45
293.21
247.69
216.47
199.38
200.57
Changes in Working Capital
-374.60
-29.02
-315.26
-341.61
-594.06
-199.76
-44.46
-49.48
-52.45
-154.37
Cash after chg. in Working capital
739.19
770.26
1,279.39
1,093.37
961.50
387.06
322.99
404.41
382.12
215.23
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-137.54
-104.57
-285.49
-182.27
-228.50
-39.64
-25.32
-61.91
-50.13
-33.26
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-681.72
-822.42
-996.06
-914.34
-940.99
-221.13
-252.88
-384.15
-288.67
-312.20
Net Fixed Assets
-360.50
-288.19
-567.41
-1,025.56
-572.84
-236.25
-254.84
-394.43
-354.15
-76.75
Net Investments
-105.35
-250.75
-22.40
-42.83
-260.57
-0.01
-6.57
-1.22
-24.40
-7.01
Others
-215.87
-283.48
-406.25
154.05
-107.58
15.13
8.53
11.50
89.88
-228.44
Cash from Financing Activity
39.28
249.83
-26.64
30.26
254.70
-127.66
-44.77
42.24
-53.61
103.32
Net Cash Inflow / Outflow
-40.79
93.10
-28.80
27.02
46.71
-1.37
0.02
0.59
-10.30
-26.91
Opening Cash & Equivalents
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53
Closing Cash & Equivalent
99.54
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
82.46
75.88
74.73
62.19
48.32
33.02
29.18
27.86
25.05
99.86
ROA
4.00%
2.10%
10.89%
13.09%
20.87%
7.34%
3.00%
6.04%
8.05%
6.61%
ROE
8.30%
4.15%
21.63%
28.05%
45.15%
15.39%
6.19%
11.97%
18.12%
18.65%
ROCE
10.16%
6.64%
22.97%
25.97%
39.82%
14.14%
8.22%
13.68%
16.52%
16.35%
Fixed Asset Turnover
0.93
0.97
1.41
1.46
1.78
1.26
1.18
1.29
1.53
1.73
Receivable days
120.60
117.42
88.66
98.37
79.52
96.76
101.97
100.40
95.66
73.56
Inventory Days
124.27
127.81
104.09
123.34
94.05
102.29
100.87
96.48
94.12
97.00
Payable days
153.14
135.42
106.10
175.76
155.37
145.69
72.80
61.13
59.14
58.52
Cash Conversion Cycle
91.73
109.81
86.64
45.95
18.21
53.36
130.03
135.75
130.64
112.05
Total Debt/Equity
0.61
0.61
0.49
0.52
0.56
0.60
0.67
0.66
0.64
1.20
Interest Cover
3.24
2.29
7.71
11.59
20.09
4.28
2.36
3.98
3.35
2.52

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Laurus Labs reports around 10-fold jump in Q2 consolidated net profit
    24th Oct 2025, 10:08 AM

    The consolidated total income of the company increased by 36.81% at Rs 1680.43 crore for Q2FY26

    Read More
  • Laurus Labs - Quarterly Results
    24th Oct 2025, 00:00 AM

    Read More
  • Laurus Labs receives 531.77 acres of land from Government of Andhra Pradesh
    28th Jul 2025, 12:37 PM

    The company has projected Rs 5,630 crore of investment and to provide employment to 6,350 people in three phases over a period of eight years

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.